All Products
CJC-1295 + Ipamorelin combines a GHRH analog with a selective ghrelin-receptor agonist. The combination has been examined in models involving complementary GHRH and GHSR signaling within the growth-hormone/IGF axis.
Follistatin-344 is the full-length 344-amino-acid follistatin isoform and a high-affinity binding protein for activin-family ligands. It has been examined in models involving TGF-beta superfamily signaling, myostatin pathways, and cellular growth regulation.
PEG-MGF is a pegylated analog of mechano growth factor designed to alter peptide stability and handling characteristics. It has been examined in models involving IGF-related signaling, muscle-cell biology, and tissue-response pathways.
MGF is a synthetic peptide corresponding to a sequence associated with the IGF-1Ec splice variant. It has been examined in cellular models involving mechanical-response signaling, muscle-cell biology, and tissue-remodeling pathways.
IGF-1 DES is a truncated insulin-like growth factor-1 analog lacking the first three amino acids of native IGF-1. It has been examined in models involving IGF-1 receptor signaling, cell growth, and metabolic pathways.
IGF-1 LR3 is a modified insulin-like growth factor-1 analog containing an extended N-terminal sequence and an arginine substitution. It has been examined in models involving IGF-1 receptor signaling, cellular growth, metabolism, and protein-synthesis pathways.
Hexarelin is a synthetic hexapeptide with growth-hormone secretagogue receptor activity. It has been examined in endocrine and cardiovascular signaling models involving GHSR-mediated pathways.
GHRP-6 is a synthetic hexapeptide and growth-hormone secretagogue receptor agonist. It has been examined in models involving ghrelin signaling, endocrine response, appetite-related pathways, and growth-hormone release.
GHRP-2 is a synthetic hexapeptide that acts at the growth-hormone secretagogue receptor. It has been examined in models involving ghrelin-receptor signaling, growth-hormone release pathways, and neuroendocrine regulation.
CJC-1295 No DAC / Mod GRF 1-29 is a modified growth hormone-releasing hormone analog based on the active 1-29 sequence. It has been examined in models involving GHRH-receptor signaling and the growth-hormone/IGF axis.
CJC-1295 DAC is a long-acting analog of growth hormone-releasing hormone designed for extended receptor signaling. It has been examined in models involving GHRH-receptor activity, growth-hormone signaling, and downstream IGF-axis pathways.
Vasoactive intestinal peptide (VIP) is a 28-amino-acid neuropeptide that signals through VPAC receptors. It has been examined in neuroendocrine, vascular, smooth-muscle, and immune-signaling models.
Thymosin Alpha-1 is a 28-amino-acid thymic peptide associated with immune-cell signaling and immune regulation. It has been examined in models involving innate and adaptive immune pathways, cytokine signaling, and T-cell function.
LL-37 is a 37-amino-acid human cathelicidin peptide involved in innate immune signaling and membrane interactions. It has been examined in models of host defense, microbial interaction, inflammation, and epithelial biology.
ARA-290, also known as cibinetide, is a short non-erythropoietic peptide derived from the helix-B region of erythropoietin. It has been examined in models involving tissue-protective receptor signaling, inflammatory pathways, and peripheral-nerve biology.
BPC-157 + TB-500 + GHK-Cu combines three peptide components associated with cellular signaling, tissue remodeling, and copper-peptide biology. The formulation has relevance to experimental models involving cell migration, extracellular-matrix activity, and angiogenic pathways.
BPC-157 + TB-500 combines two synthetic peptides commonly examined in tissue-response and cellular-signaling models. The combination brings together pathways associated with angiogenic signaling, cell migration, cytoskeletal regulation, and extracellular-matrix activity.
Thymosin Beta-4 is a naturally occurring 43-amino-acid peptide with a central role in actin binding and cytoskeletal regulation. It has been examined in models involving cell migration, angiogenic signaling, and tissue-remodeling pathways.
TB-500 is a synthetic peptide commonly associated with an active region of thymosin beta-4. It has been examined in relation to actin dynamics, cell migration, angiogenic signaling, and tissue-response pathways.
BPC-157 is a synthetic 15-amino-acid peptide derived from a protective gastric protein sequence. It has been examined in models involving tissue-response signaling, angiogenic pathways, gastrointestinal biology, and cellular repair mechanisms.
Oxytocin is a cyclic nonapeptide hormone produced in the hypothalamic-neurohypophyseal system. It has been examined across oxytocin-receptor signaling, neuroendocrine regulation, smooth-muscle biology, and social-behavior pathways.
Gonadorelin is the synthetic form of the naturally occurring gonadotropin-releasing hormone decapeptide. It has been characterized for GnRH-receptor signaling and downstream pituitary gonadotropin pathways.
Kisspeptin-54 is a 54-amino-acid peptide derived from the KISS1 precursor protein. It signals through the KISS1 receptor and has been examined in models involving hypothalamic regulation, GnRH signaling, and reproductive endocrinology.
Kisspeptin-10 is the biologically active C-terminal decapeptide fragment of kisspeptin. It is a potent KISS1 receptor ligand and has been examined in models involving hypothalamic signaling, GnRH release, and reproductive neuroendocrine pathways.
Bremelanotide, also known as PT-141, is a cyclic melanocortin peptide analog derived from alpha-melanocyte-stimulating hormone. It acts at melanocortin receptors and has been characterized in neuroendocrine and melanocortin-signaling pathways.
Pinealon is the synthetic tripeptide Glu-Asp-Arg (EDR). It has been examined in neuronal and cellular-aging models involving gene expression, neuroendocrine signaling, oxidative balance, and stress-response pathways.
Thymalin is a thymus-derived peptide complex composed of short regulatory peptides. It has been examined in models involving thymic signaling, immune-cell regulation, cellular homeostasis, and age-related immune changes.
Humanin is a mitochondria-derived peptide encoded within mitochondrial 16S rRNA. It has been examined in models involving cellular stress responses, mitochondrial signaling, apoptosis regulation, and neuronal biology.
HGH Fragment 176-191 is a synthetic peptide corresponding to the C-terminal region of human growth hormone. It has been examined in models involving adipocyte biology, lipid metabolism, and growth-hormone-fragment signaling.
AOD-9604 is a synthetic peptide derived from the C-terminal region of human growth hormone. It has been examined in models involving lipid metabolism, adipocyte signaling, and growth-hormone-fragment biology.
Mazdutide is a synthetic dual agonist of GLP-1 and glucagon receptors. It has been examined in models involving glucose regulation, lipid metabolism, appetite signaling, and energy expenditure.
Semaglutide is a long-acting peptide analog of glucagon-like peptide-1 (GLP-1). It has been extensively characterized for GLP-1 receptor signaling, glucose-regulatory pathways, appetite signaling, and metabolic biology.
Tesamorelin is a stabilized synthetic analog of growth hormone-releasing hormone. It has been characterized for GHRH-receptor activity and downstream growth-hormone and IGF-axis signaling.
Sermorelin is a synthetic 29-amino-acid analog of the biologically active region of growth hormone-releasing hormone. It has been examined in connection with GHRH-receptor signaling and the growth-hormone/IGF axis.
Ipamorelin is a synthetic pentapeptide and selective ghrelin-receptor agonist. It has been examined in models involving growth-hormone secretagogue signaling, GHSR activity, and neuroendocrine pathways.
KPV is the tripeptide Lys-Pro-Val and corresponds to the C-terminal fragment of alpha-melanocyte-stimulating hormone. It has been examined in connection with inflammatory signaling, epithelial biology, and immune-response pathways.
Survodutide is a synthetic dual agonist targeting glucagon and GLP-1 receptors. It has been examined in models involving hepatic metabolism, glucose regulation, energy balance, and incretin signaling.
Cagrilintide + Semaglutide combines a long-acting amylin analog with a GLP-1 receptor agonist. The combination has been examined in models involving complementary amylin and GLP-1 signaling, appetite regulation, and metabolic pathways.
Cagrilintide is a long-acting amylin analog designed for sustained amylin-receptor signaling. It has been examined in models involving appetite regulation, gastric signaling, glucose homeostasis, and metabolic pathways.
Retatrutide is a synthetic peptide designed as a triple agonist of GIP, GLP-1, and glucagon receptors. It has been examined in models involving multi-receptor incretin signaling, glucose regulation, lipid metabolism, and energy balance.
Cerebrolysin is a complex mixture of low-molecular-weight peptides and amino acids derived from porcine brain proteins. It has been characterized in neuronal models involving neurotrophic signaling, cellular survival pathways, and synaptic biology.
Dihexa is a cell-permeable peptidomimetic derived from an angiotensin IV-related scaffold. It has been examined in neuronal models involving hepatocyte growth factor/c-Met signaling, synaptic connectivity, and neuroplasticity.
DSIP, or delta sleep-inducing peptide, is a naturally described nonapeptide. It has been examined in neuroendocrine models involving sleep-related signaling, stress-response pathways, and central nervous system regulation.
Selank is a synthetic heptapeptide analog of the naturally occurring tetrapeptide tuftsin. It has been examined in neurochemical and immune-signaling models involving neurotransmitter pathways, stress-response signaling, and immune modulation.
Semax is a synthetic heptapeptide derived from the ACTH(4-7) sequence with an added Pro-Gly-Pro fragment. It has been examined in neuronal models involving neurotrophic signaling, synaptic pathways, oxidative balance, and cognitive biology.
NAD+ is a ubiquitous pyridine nucleotide coenzyme central to cellular redox reactions and energy metabolism. It also serves as a substrate for enzymes involved in DNA repair, protein deacylation, and cellular signaling.
Epitalon, also known as Epithalon, is the synthetic tetrapeptide Ala-Glu-Asp-Gly (AEDG). It has been examined in cellular-aging, gene-expression, pineal-signaling, and telomere-associated experimental models.
SS-31, also known as elamipretide, is a mitochondria-targeting aromatic-cationic tetrapeptide with affinity for cardiolipin. It has been characterized in models involving inner-mitochondrial-membrane function, bioenergetics, and oxidative-stress signaling.
Cartalax is the synthetic tripeptide Ala-Glu-Asp (AED). It has been examined in connective-tissue, cartilage, fibroblast, and cellular-aging models involving gene expression and tissue-specific signaling.
Bronchogen is the synthetic tetrapeptide Ala-Glu-Asp-Leu (AEDL). It has been examined in bronchial epithelial and pulmonary cell models involving tissue-specific gene expression and cellular regulatory pathways.
Vesugen is the synthetic tripeptide Lys-Glu-Asp (KED). It has been examined in vascular and endothelial cell models involving gene expression, cellular signaling, vascular-wall biology, and age-related cellular change.
CardioGen is the synthetic tetrapeptide Ala-Glu-Asp-Arg (AEDR). It has been examined in cardiovascular cell models involving gene expression, protein synthesis, cardiomyocyte biology, and tissue-specific signaling.
FOXO4-DRI is a D-retro-inverso, cell-permeable peptide designed to disrupt the interaction between FOXO4 and p53. It has been examined in cellular-senescence models involving p53 localization, apoptosis signaling, and senescent-cell biology.
PNC-27 is a chimeric p53-derived peptide incorporating a cell-penetrating sequence. It has been examined for interactions with membrane-associated HDM-2 and related cellular-signaling and membrane-pore models.
Melanotan II is a synthetic cyclic peptide analog of alpha-melanocyte-stimulating hormone. It acts at multiple melanocortin receptors and has been examined in pigmentation, neuroendocrine, and melanocortin-signaling models.
Melanotan I, also known as afamelanotide, is a synthetic linear analog of alpha-melanocyte-stimulating hormone. It has high affinity for the melanocortin-1 receptor and has been characterized in melanocortin signaling and pigmentation biology.
AHK-Cu is a copper-binding tripeptide complex composed of alanine, histidine, and lysine. It has been examined in connection with copper-peptide signaling, dermal tissue biology, extracellular-matrix activity, and hair-follicle pathways.
5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT). It has been examined in cellular and metabolic models involving NAD-related pathways, methylation balance, adipocyte biology, and energy metabolism.
MOTS-C is a 16-amino-acid mitochondria-derived peptide encoded within mitochondrial 12S rRNA. It has been examined in models involving cellular metabolism, mitochondrial signaling, glucose utilization, energy regulation, and stress-response pathways.
GHK-Cu is the copper(II) complex of the naturally occurring tripeptide Gly-His-Lys. It has been examined in connection with copper transport, extracellular-matrix signaling, dermal-cell biology, oxidative pathways, and tissue remodeling.
Tirzepatide is a synthetic peptide with dual agonist activity at GIP and GLP-1 receptors. It has been characterized in models involving incretin signaling, glucose regulation, energy balance, and metabolic pathways.
Functional endometrial diagnostic based on patient-derived endometrial organoids and stem-cell-derived blastoids. A biopsy is used to create an organoid model of the patient’s endometrium; blastoids are then introduced to model implantation, with hCG production and blastoid invasion used as functional readouts.
A proteomic biomarker platform developed to support prediction and stratification of pulmonary disease progression in cystic fibrosis. The technology evaluates defined protein-expression signatures from patient samples to identify patterns associated with future lung-function outcomes, creating potential applications in earlier clinical intervention, patient stratification, longitudinal monitoring, and clinical research.
Cell-free extracellular vesicle formulation derived from engineered chimeric antigen receptor natural killer (CAR-NK) cells, produced under controlled laboratory conditions and characterized for defined identity, purity, and quality specifications.
